플랫폼 신규버전 기능 안내 및 연구개발 Data Integrity 대응 전략
Dotmatics 플랫폼의 2022.4 버전부터 통합된 Browser 기반 데이터 분석 툴 Workspace의 기능 데모와 연구개발 분야 데이터 완전성 대응 전략을 2024년 4월 30일 오전 10시부터 온라인으로 안내하는 이벤트입니다.
Dotmatics 플랫폼의 새로운 버전 출시에 따라 새롭게 바뀐 기능을 버전별로 안내합니다. 2022.4 버전부터 Browser 기능으로 통합된 데이터 분석 툴인 Workspace의 활용법을 데모 형식으로 소개할 예정입니다.
또한, 연구개발 분야에서 데이터 완전성(Data Integrity) 대응을 위한 전략에 대해 공유할 예정입니다.
이벤트 정보
- 일시: 2024년 4월 30일 (수요일)
- 시간: 오전 10:00 - 11:30 (KST)
- 방식: 온라인 (Virtual)
Related
Addressing Inefficient R&D Workflows
The blog discusses how legacy, fragmented R&D systems hinder innovation in complex, multi-domain scientific research by creating silos and inefficiencies, and presents Dotmatics’ unifying platform as a comprehensive solution that integrates diverse tools, data, and teams to enable smarter collaboration, governed data use, and AI-driven automation for faster, more rigorous innovation.
Optimizing Bial’s Life-Changing Drug R&D
Bial, a biopharmaceutical leader in neuroscience and rare diseases, overcame fragmented software and collaboration challenges by adopting Dotmatics' unified SaaS platform, which streamlined R&D workflows, enhanced data accessibility, reduced IT complexity, and enabled researchers to focus on developing life-changing treatments.
Dotmatics Set to Transform the Future of Scientific Software and Data Management
Dotmatics, formed from the merger of Insightful Science and Dotmatics, is launching a powerful integrated enterprise R&D platform combining its scientific software with popular applications like SnapGene, Geneious, and GraphPad Prism to address complex data challenges and accelerate scientific research and collaboration for over two million scientists and 10,000 customers worldwide.
Dotmatics Summit 2023 Boston
The Dotmatics Summit 2023 in Boston on October 11-12 offers a day and a half of sessions and discussions focused on advancing data-driven decision making and AI-powered innovation in R&D, featuring presentations from Dotmatics leadership on lab integration and platform updates, customer spotlights, partner collaborations, and interactive panels, all held at The Royal Sonesta with networking opportunities.
Addex Therapeutics: Creating Novel Small Molecule Drugs for Patients with CNS Diseases
Addex Therapeutics, a Geneva-based biotech developing novel oral small molecule drugs for CNS diseases like Parkinson’s and Alzheimer’s, overcame challenges of outdated data management and complex R&D workflows by implementing the Dotmatics platform, which modernized their data handling, streamlined analysis, and significantly saved scientists’ time, thereby accelerating innovation.
Dotmatics Demo for Chemicals & Materials
Dotmatics offers the first true end-to-end scientific R&D software platform that digitizes and automates lab functions across multiple disciplines—including synthetic chemistry, polymer science, and materials innovation—enabling over 2 million researchers to access high-quality data, overcome informatics challenges, and accelerate multimodal discovery for chemicals and materials.